Lin David D, Picardo Natasha E, Adesida Adetola, Khan Wasim S
Royal London Hospital, Barts Health NHS Trust, Whitechapel Rd, London E1 1BB, United Kingdom.
University of Alberta, 16 St & 85 Ave, Edmonton, AB T6G 2R3, United Kingdom.
Curr Stem Cell Res Ther. 2017;12(4):348-353. doi: 10.2174/1574888X11666160429123110.
Meniscal injury is a common problem among sportsmen and increasingly seen in the older and more active population. The traditional treatment options include a partial meniscectomy, which provides good mechanical and pain relief to the patient. However, the focus of treatment is shifting towards repairing meniscal tears where possible and replacement of the lost meniscal tissue where appropriate. Replacement can be total or partial. Total meniscal replacement using an allograft, is usually reserved for young patients, who meet certain criteria and who have undergone several subtotal meniscectomies or a single stage total meniscectomy and are still symptomatic. Partial meniscal replacement can be utilized in conjunction with a partial meniscectomy to fill the resulting space left by the resection. Collagen based implants and synthetic scaffolds have entered the European market but have demonstrated mixed results in clinical trials. Tissue engineering to create an implant that mimics the biomechanical properties holds much potential for future research.
半月板损伤在运动员中是一个常见问题,并且在年龄较大、活动较多的人群中越来越常见。传统的治疗选择包括部分半月板切除术,这能为患者提供良好的力学改善和疼痛缓解。然而,治疗的重点正转向尽可能修复半月板撕裂,并在适当情况下替换缺失的半月板组织。替换可以是全部或部分的。使用同种异体移植物进行全半月板置换通常适用于符合特定标准、已经接受过多次次全半月板切除术或一期全半月板切除术且仍有症状的年轻患者。部分半月板置换可与部分半月板切除术联合使用,以填充切除后留下的空间。基于胶原蛋白的植入物和合成支架已进入欧洲市场,但在临床试验中显示出的结果参差不齐。通过组织工程制造出模仿生物力学特性的植入物在未来研究中有很大潜力。